<DOC>
	<DOCNO>NCT02501876</DOCNO>
	<brief_summary>In recent year , observe type 2 diabetic patient ( DM-2 ) increase risk develop dementia , vascular Alzheimer 's disease ( AD ) . The term mild cognitive impairment ( MCI ) describe transition state normal cognitive function dementia . The annual rate conversion dementia MCI patient around 15 % general population , regardless presence absence diabetes . At present possible identify patient MCI likely progress AD . On basis , main objective study evaluate whether presence diabetes presence relate gene favor conversion MCI AD .</brief_summary>
	<brief_title>Type 2 Diabetes Mellitus Catalyst Alzheimer 's Disease</brief_title>
	<detailed_description>In recent year , observe type 2 diabetic patient ( DM-2 ) increase risk develop dementia , vascular Alzheimer 's disease ( AD ) . The term mild cognitive impairment ( MCI ) describe transition state normal cognitive function dementia . The annual rate conversion dementia MCI patient around 15 % general population , ie regardless presence absence diabetes . At present possible identify patient MCI likely progress AD . On basis , main objective study evaluate whether presence diabetes favor conversion MCI AD . We propose case-control study compare group 110 diabetic patient group 110 non-diabetic patient MCI match age , sex cardiovascular risk factor . The main objective conversion AD group DM-2 independent risk factor . The secondary objective investigate whether genetic mechanism relate AD DM-2 associate increase risk AD diabetic patient . We analyze 10 gene simultaneously associate increase risk diabetes / complication AD .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>diagnosis MCI use NBACE neuropsychological test battery . Age &gt; 65 year . At least two year followup . 110 subject type 2 diabetes 110 subject without diabetes write informed consent . patient cerebrovascular disease ( previous stroke , intracerebral lesion , etc . ) , include significant vascular load accord scale Fazekas ( escorËƒ2 )</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>The risk progession</keyword>
	<keyword>patient</keyword>
</DOC>